Abstract
Even though the primacy of surgical resection has been challenged by the era of definitive radiochemotherapy for locally advanced squamous cell carcinomas of the oesophagus, it has reestablished itself as the treatment of choice for the majority of operable patients as it allows for enhanced loco-regional disease control and a prolonged survival. To obtain such results, surgical managementmust achieve certain quality criteria, not only on the operative front but also at the levels of organisation and patient peri-operative care. This document provides an update regarding the current quality criteria for the oncological resection of cancers of the oesophagus and oesophago-gastric junction.
Résumé
Bien que la chirurgie ait été challengée pendant un temps par la radiochimiothérapie exclusive dans les carcinomes épidermoïdes localement avancés de l’oesophage, elle redevient pour la majorité des patients opérables le traitement de référence, car permettant un meilleur contrôle locorégional de la maladie et des survies prolongées. Pour obtenir ces résultats, la chirurgie doit répondre à des critères de qualité tant sur le plan chirurgical qu’organisationnel et périopératoire. Cette mise au point fait état des critères de qualité de la chirurgie des cancers de l’œsophage (CO) et de la jonction œsogastrique.
Similar content being viewed by others
Références
Akiyama H, Tsurumaru M, Udagawa H, et al. (1994) Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 220: 364–372
Altorki N, Skinner D (2001) Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg 234: 581–587
Altorki N, Kent M, Ferrara C, et al. (2002) Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236: 177–183
Begg CB, Cramer LD, Hoskins WJ, et al. (1998) Impact of hospital volume on operative mortality for major cancer surgery. JAMA 280: 1747–1751
Biere SS, van Berge Henegouwen MI, Maas KW, et al. (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 379: 1887–1892
Birkmeyer JD, Stukel TA, Siewers AE, et al. (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349: 2117–2127
Bosset JF, Gignoux M, Triboulet JP, et al. (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337: 161–167
Briez N, Piessen G, Bonnetain F, et al. (2011) Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial—the MIRO trial. BMC Cancer 11: 310
Casson AG, Darnton SJ, Subramanian S, Hiller L (2000) What is the optimal distal resection margin for esophageal carcinoma? Ann Thorac Surg 69: 205–209
Dexter SP, Sue-Ling H, McMahon MJ, et al. (2001) Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut 48: 667–670
Gruen RL, Pitt V, Green S, et al. (2009) The effect of provider case volume on cancer mortality: systematic review and metaanalysis. CA Cancer J Clin 59: 192–211
Hagen JA, DeMeester SR, Peters JH, et al. (2001) Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 234: 520–530
Hulscher JB, van Sandick JW, Tijssen JG, et al. (2000) The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg 191: 143–148
Hulscher JB, van Sandick JW, de Boer AG, et al. (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347: 1662–1669
Johansson J, DeMeester TR, Hagen JA, et al. (2004) En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus. Arch Surg 139: 627–631
Kato H, Tachimori Y, Watanabe H, et al. (1996) Recurrent esophageal carcinoma after esophagectomy with three-field lymph node dissection. J Surg Oncol 61: 267–272
Mariette C, Piessen G, Triboulet JP (2007) Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 8: 545–553
Mariette C, Piessen G, Briez N, et al. (2008) The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 247: 365–371
Mariette C, Piessen G, Briez N, et al. (2011) Oesophagogastric junction adenocarcinoma: which therapeutic approach? Lancet Oncol 12: 296–305
Mariette C, Piessen G (2012) Oesophageal cancer: how radical should surgery be? Eur J Surg Oncol 38: 210–213
Mariette C, Robb WB (2012) Minimally invasive versus open oesophagectomy for oesophageal cancer. Lancet 380: 883
Mariette C, Robb WB (2012) Open or minimally invasive resection for oesophageal cancer? Recent Results in Cancer Research 196: 155–167
Nagatani S, Shimada Y, Kondo M, et al. (2005) A strategy for determining which thoracic esophageal cancer patients should undergo cervical lymph node dissection. Ann Thorac Surg 80: 1881–1886
Nishihira T, Hirayama K, Mori S (1998) A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 175: 47–51
Omloo JM, Lagarde SM, Hulscher JB, et al. (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/ distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 246: 992–1000
Peyre CG, Hagen JA, DeMeester SR, et al. (2008) The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248: 549–556
Rouvelas I, Zeng W, Lindblad M, et al. (2005) Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol 6: 864–870
Sasako M, Sano T, Yamamoto S, et al. (2006) Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol 7: 644–651
Sauvanet A, Mariette C, Thomas P, et al. (2005) Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors. J Am Coll Surg 201: 253–262
Siewert JR, Stein HJ, Feith M, et al. (2001) Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 234: 360–367
Sjoquist KM, Burmeister BH, Smithers BM, et al. (2011) Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 12: 681–692
Slim K, Blay JY, Brouquet A, et al. (2009) Digestive oncology: surgical practices. J Chir (Paris) 146(Suppl 2): S11–S80
Tachibana M, Kinugasa S, Yoshimura H, et al. (2003) Extended esophagectomy with 3-field lymph node dissection for esophageal cancer. Arch Surg 138: 1383–1389
Wu PC, Posner MC (2003) The role of surgery in the management of oesophageal cancer. Lancet Oncol 4: 481–488
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Mariette, C., Robb, W.B. & Piessen, G. Critères de qualité de la chirurgie des cancers de l’œsophage et de la jonction œsogastrique. Oncologie 15, 133–138 (2013). https://doi.org/10.1007/s10269-013-2264-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10269-013-2264-z